This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Navidea Biopharmaceuticals, Inc.. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Needham, MA (US) (2013)
- Powell, OH (US) (2016)
Company Filing History:
Years Active: 2013-2016
Title: Innovations by Gerald Ross Magneson
Introduction
Gerald Ross Magneson is an accomplished inventor based in Powell, Ohio. He has made significant contributions to the field of radiolabeling, particularly with his innovative compositions for diethylenetriaminepentaacetic acid (DTPA)-dextran. With a total of two patents to his name, Magneson's work has the potential to enhance clinical practices in medical imaging.
Latest Patents
Magneson's latest patents focus on compositions for radiolabeling DTPA-dextran with Technetium-99m. These compositions are designed to stabilize the DTPA-dextran Cold Kit. The formulation includes Stannous Chloride ions, Ascorbic Acid, α,α-Trehalose, and Glycine, which work together to maintain a reducing environment and facilitate high radiochemical purity. The invention also introduces a Diluent vial that adjusts the pH to a moderately acidic level, reducing pain during injection and improving usability for clinical practitioners.
Career Highlights
Gerald Ross Magneson is currently associated with Navidea Biopharmaceuticals, Inc., where he continues to innovate in the field of biopharmaceuticals. His work is characterized by a commitment to improving medical imaging techniques and patient comfort.
Collaborations
Magneson collaborates with Richard Cushman Orahood, contributing to advancements in their shared field of expertise.
Conclusion
Gerald Ross Magneson is a notable inventor whose work in radiolabeling compositions has the potential to significantly impact medical imaging practices. His innovative approaches and collaborations continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile